Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Form panel to disburse medical claim under CGHS: SC to Centre

      Form panel to disburse medical claim under CGHS: SC to Centre

      Ruby Khatun Khatun15 April 2018 10:45 AM IST
      New Delhi: In a bid to protect retired public servants from "unnecessary harassment" in claiming reimbursements under the Central Government Health...
      Mylan seeks deal for German Mercks consumer products unit: sources

      Mylan seeks deal for German Merck's consumer products unit: sources

      Ruby Khatun Khatun15 April 2018 10:15 AM IST
      FRANKFURT/NEW YORK: Generic drug maker Mylan NV is in advanced discussions to acquire Merck KGaA’s consumer health business after other bidders failed...
      CVS Health appoints Marc-David Munk as CMO of MinuteClinic

      CVS Health appoints Marc-David Munk as CMO of MinuteClinic

      Ruby Khatun Khatun15 April 2018 10:00 AM IST
      CVS Health on Friday named Marc-David Munk as the new chief medical officer of MinuteClinic, the drugstore chain’s retail medical clinic unit and as...
      GSK slims portfolio with sale of rare disease gene therapy drugs

      GSK slims portfolio with sale of rare disease gene therapy drugs

      Ruby Khatun Khatun15 April 2018 9:45 AM IST
      LONDON: GlaxoSmithKline (GSK) is divesting its rare disease gene therapy drugs to private biotech company Orchard Therapeutics as Chief Executive Emma...
      HDFC looks to buy Apollo Munich insurance for Rs 1,000 crore

      HDFC looks to buy Apollo Munich insurance for Rs 1,000 crore

      Ruby Khatun Khatun15 April 2018 9:00 AM IST
      New Delhi: HDFC is in discussion to buy Apollo Munich Health Insurance Company for an approximate valuation of Rs 1,000 crore, a recent report in ET...
      IHH offers Rs 160 per share for Fortis healthcare

      IHH offers Rs 160 per share for Fortis healthcare

      Ruby Khatun Khatun14 April 2018 10:30 AM IST
      New Delhi: Malaysia's IHH Healthcare has joined the race to acquire India's troubled Fortis Healthcare, offering to acquire shares at up to Rs 160...
      50 percent hike in cigarette prices would add 450 million years of life across 13 nations: study

      50 percent hike in cigarette prices would add 450 million years of life across 13 nations: study

      Ruby Khatun Khatun14 April 2018 10:00 AM IST
      New Delhi: A fifty percent hike in cigarette prices would lead to about 450 million years of life gained across thirteen middle-income countries,...
      Sanofi to invest 432.4 million dollars in Canada vaccine facility

      Sanofi to invest 432.4 million dollars in Canada vaccine facility

      Ruby Khatun Khatun14 April 2018 9:45 AM IST
      PARIS: French healthcare group Sanofi is investing 350 million euros ($432.4 million) in a Canadian vaccine facility, which the drugmaker said would...
      Loxo, Illumina to partner for diagnostic tool targeting cancer

      Loxo, Illumina to partner for diagnostic tool targeting cancer

      Ruby Khatun Khatun14 April 2018 9:30 AM IST
      Drug developer Loxo Oncology said it is partnering with genetic testing company Illumina Inc on a diagnostic tool that will work with Loxo’s...
      Founders of Dabur, Hero jointly bid Rs 1,250 crore for Fortis

      Founders of Dabur, Hero jointly bid Rs 1,250 crore for Fortis

      Ruby Khatun Khatun13 April 2018 1:29 PM IST
      New Delhi: Fortis Healthcare said it has received an "unsolicited binding offer" from Hero Enterprise Investment Office and Burman Family Office to...
      Strides Shasun arm gets USFDA nod for allergy relief drug

      Strides Shasun arm gets USFDA nod for allergy relief drug

      Ruby Khatun Khatun13 April 2018 11:15 AM IST
      New Delhi: Strides Shasun said its wholly-owned subsidiary has received approval from the US health regulator for Cyproheptadine Hydrochloride...
      USFDA approves AI device to detect diabetic eye disease

      USFDA approves AI device to detect diabetic eye disease

      Ruby Khatun Khatun13 April 2018 10:45 AM IST
      U.S. health regulators said it will allow the sale of the first medical device that uses artificial intelligence (AI) software to detect greater than...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok